Clinical Policy: Critical Issues in the Management of Adult Patients Presenting to the Emergency Department With Community-Acquired Pneumonia

Annals of Emergency Medicine

Volumn 54, Issue 5, 2009, Pages 704-731

  Nazarian, Devorah J ^a   Eddy, Orin L ^a   Lukens, Thomas W ^a   Weingart, Scott D ^a   Decker, Wyatt W ^a  

^a American Coll of Emergency Physicians Clinical Policies Subcommittee (Writing Committee) on Critica   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

BLOOD CULTURE; COMMUNITY ACQUIRED PNEUMONIA; COST EFFECTIVENESS ANALYSIS; HEALTH CARE; HEALTH CARE POLICY; HEALTH CARE QUALITY; HUMAN; MEDICAL PRACTICE; MORBIDITY; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TREATMENT OUTCOME;

ADULT; AGED; ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EDUCATION, MEDICAL, CONTINUING; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEALTH POLICY; HUMANS; INFECTION CONTROL; MALE; MIDDLE AGED; PNEUMONIA; POLICY MAKING; PRACTICE GUIDELINES AS TOPIC; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 70350065937     PISSN: 01960644     EISSN: 10976760     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2009.07.002     Document Type: Review

References (57)

1. Arias E., and Smith B.L. Deaths: preliminary data for 2001. Natl Vital Stat Rep 51 (2003) 1-44
2. Centers for Medicare and Medicaid Services. Medicare and Medicaid statistical supplement, 1995. Healthcare Finance Rev Stat Suppl (1995) 1-388
3. Halm E.A., and Tierstein A.S. Clinical practice. Management of community-acquired pneumonia. N Engl J Med 347 (2002) 2039-2045
4. Feikin D.R., Schuchat A., Kolczak M., et al. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am J Public Health 90 (2000) 223-229
5. Talan P.A., DeBleuix P., and Kollef M.H. A new paradigm in emergency medicine: healthcare-associated pneumonia. Clinical Courier 25 (2007) 1-16
6. American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171 (2005) 388-416
7. Kollef M.H., Shorr A., Tabak Y.P., et al. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 128 (2005) 3854-3862
8. Hiramatsu K., and Niederman M.S. Health-care-associated pneumonia: a new therapeutic paradigm. Chest 128 (2005) 3784-3787
9. The Joint Commission. Specifications manual for national hospital quality measures. http://www.jointcommission.org/PerformanceMeasurement/PerformanceMeasurement/Current+NHQM+Manual.htm Accessed May 15, 2009.
10. Pines J.M., Hollander J.E., Lee H., et al. Emergency department operational changes in response to pay-for-performance and antibiotic timing in pneumonia. Acad Emerg Med 14 (2007) 545-548
11. Kanwar M., Brar N., Khatib R., et al. Misdiagnosis of community-acquired pneumonia and inappropriate utilization of antibiotics: side effects of the 4-h antibiotic administration rule. Chest 131 (2007) 1865-1869
12. Khalil A., Kelen G., and Rothman R.E. A simple screening tool for identification of community-acquired pneumonia in an inner city emergency department. Emerg Med J 24 (2007) 336-338
13. Metersky M.L., Sweeney T.A., Getzow M.B., et al. Antibiotic timing and diagnostic uncertainty in Medicare patients with pneumonia. Is it reasonable to expect all patients to receive antibiotics within 4 hours?. Chest 130 (2006) 16-21
14. Fee C., Weber E.J., Maak C.A., et al. Effect of emergency department crowding on time to antibiotics in patients admitted with community-acquired pneumonia. Ann Emerg Med 50 (2007) 501-509
15. Pines J.M., Localio A.R., Hollander J.E., et al. The impact of emergency department crowding measures on time to antibiotics for patients with community-acquired pneumonia. Ann Emerg Med 50 (2007) 510-516
16. Pines J.M., Hollander J.E., Localio A.R., et al. The association between emergency department crowding and hospital performance on antibiotic timing for pneumonia and percutaneous intervention for myocardial infarction. Acad Emerg Med 13 (2006) 873-878
17. Capelastegui A., Espana P.P., Quintana J.M., et al. Validation of a predictive rule for the management of community-acquired pneumonia. Eur Respir J 27 (2006) 151-157
18. Aujesky D., Auble T.E., Yealy D.M., et al. Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am J Med 118 (2005) 384-392
19. Fine M.J., Auble T.E., Yealy D.M., et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336 (1997) 243-250
20. Lim W.S., van der Eerden M.M., Laing R., et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58 (2003) 377-382
21. Yealy D.M., Auble T.E., Stone R.A., et al. The emergency department community-acquired pneumonia trial: methodology of a quality improvement intervention. Ann Emerg Med 43 (2004) 770-782
22. Walls R.M., and Resnick J. The Joint Commission on Accreditation of Healthcare Organizations and Center for Medicare and Medicaid Services community-acquired pneumonia initiative: what went wrong?. Ann Emerg Med 46 (2005) 409-411
23. Fee C., Sharpe B.A., Nguy M., et al. JCAHO/CMS core measures for community-acquired pneumonia. Ann Emerg Med 47 (2006) 505-506
24. Moran G.J., and Abrahamian F.M. Blood cultures for community-acquired pneumonia: can we hit the target without a shotgun?. Ann Emerg Med 46 (2005) 407-408
25. Rothman R.E., Quianzon C.C.L., and Kelen G.D. Narrowing in on JCAHO recommendations for community-acquired pneumonia. Acad Emerg Med 13 (2006) 983-985
26. Schriger D.L., Cantrill S.V., and Greene C.S. The origins, benefits, harms, and implications of emergency medicine clinical policies. Ann Emerg Med 22 (1993) 597-602
27. Mandell L.A., Wunderink R.G., Anzueto A., et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44 (2007) S27-S72
28. Theerthakarai R., El-Halees W., Ismail M., et al. Nonvalue of the initial microbiological studies in the management of nonsevere community-acquired pneumonia. Chest 119 (2001) 181-184
29. Paganin F., Lilienthal F., Bourdin A., et al. Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor. Eur Respir J 24 (2004) 779-785
30. Beovic B., Bonac B., Kese D., et al. Aetiology and clinical presentation of mild community-acquired bacterial pneumonia. Eur J Clin Microbiol Infect Dis 22 (2003) 584-591
31. Campbell S.G., Marrie T.J., Anstey R., et al. The contribution of blood cultures to the clinical management of adult patients admitted to the hospital with community-acquired pneumonia: a prospective observational study. Chest 123 (2003) 1142-1150
32. Chalasani N.P., Valdecanas M.A., Gopal A.K., et al. Clinical utility of blood cultures in adult patients with community-acquired pneumonia without defined underlying risks. Chest 108 (1995) 932-936
33. Corbo J., Friedman B., Bijur P., et al. Limited usefulness of initial blood cultures in community acquired pneumonia. Emerg Med J 21 (2004) 446-448
34. El-Solh A.A., Sikka P., Ramadan F., et al. Etiology of severe pneumonia in the very elderly. Am J Respir Crit Care Med 163 (2001) 645-651
35. Ewig S., Bauer T., Hasper E., et al. Value of routine microbial investigation in community-acquired pneumonia treated in a tertiary care center. Respiration 63 (1996) 164-169
36. Fine M.J., Stone R.A., Singer D.E., et al. Processes and outcomes of care for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team (PORT) cohort study. Arch Intern Med 159 (1999) 970-980
37. Glerant J.C., Hellmuth D., Schmit J.L., et al. Utility of blood cultures in community-acquired pneumonia requiring hospitalization: influence of antibiotic treatment before admission. Respir Med 93 (1999) 208-212
38. Waterer G.W., and Wunderink R.G. The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures. Respir Med 95 (2001) 78-82
39. Kennedy M., Bates D.W., Wright S.B., et al. Do emergency department blood cultures change practice in patients with pneumonia?. Ann Emerg Med 46 (2005) 393-400
40. Metersky M.L., Ma A., Bratzler D.W., et al. Predicting bacteremia in patients with community-acquired pneumonia. Am J Respir Crit Care Med 169 (2004) 342-347
41. van der Eerden M.M., Vlaspolder F., de Graaff C.S., et al. Value of intensive diagnostic microbiological investigation in low- and high-risk patients with community-acquired pneumonia. Eur J Clin Microbiol Infect Dis 24 (2005) 241-249
42. Ramanujam P., and Rathlev N.K. Blood cultures do not change management in hospitalized patients with community-acquired pneumonia. Acad Emerg Med 13 (2006) 740-745
43. Socan M., Marinic-Fiser N., Kraigher A., et al. Microbial aetiology of community-acquired pneumonia in hospitalized patients. Eur J Clin Microbiol Infect Dis 18 (1999) 777-782
44. Woodhead M.A., Arrowsmith J., Chamberlain-Webber R., et al. The value of routine microbial investigation in community-acquired pneumonia. Respir Med 85 (1991) 313-317
45. Sanyal S., Smith P.R., Saha A.C., et al. Initial microbiologic studies did not affect outcome in adults hospitalized with community-acquired pneumonia. Am J Respir Crit Care Med 160 (1999) 346-348
46. Waterer G.W., Jennings S.G., and Wunderink R.G. The impact of blood cultures on antibiotic therapy in pneumococcal pneumonia. Chest 116 (1999) 1278-1281
47. Dedier J., Singer D.E., Chang Y., et al. Processes of care, illness severity, and outcomes in the management of community-acquired pneumonia at academic hospitals. Arch Intern Med 161 (2001) 2099-2104
48. Meehan T.P., Fine M.J., Krumholz H.M., et al. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA 278 (1997) 2080-2084
49. Bates D.W., Goldman L., and Lee T.H. Contaminant blood cultures and resource utilization. The true consequences of false-positive results. JAMA 265 (1991) 365-369
50. Lujan M., Gallego M., Fontanals D., et al. Prospective observational study of bacteremic pneumococcal pneumonia: effect of discordant therapy on mortality. Crit Care Med 32 (2004) 625-631
51. Moine P., Vercken J.B., Chevret S., et al. Severe community-acquired pneumonia. Etiology, epidemiology, and prognosis factors. French Study Group for Community-Acquired Pneumonia in the Intensive Care Unit. Chest 105 (1994) 1487-1495
52. Houck P.M. Antibiotics and pneumonia: is timing everything or just a cause of more problems?. Chest 130 (2006) 1-3
53. Houck P.M., Bratzler D.W., Nsa W., et al. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 164 (2004) 637-644
54. Waterer G.W., Kessler L.A., and Wunderink R.G. Delayed administration of antibiotics and atypical presentation in community-acquired pneumonia. Chest 130 (2006) 11-15
55. Silber S.H., Garrett C., Singh R., et al. Early administration of antibiotics does not shorten time to clinical stability in patients with moderate-to-severe community-acquired pneumonia. Chest 124 (2003) 1798-1804
56. Marrie T.J., and Wu L. Factors influencing in-hospital mortality in community-acquired pneumonia: a prospective study of patients not initially admitted to the ICU. Chest 127 (2005) 1260-1270
57. Battleman D.S., Callahan M., and Thaler H.T. Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia: link between quality of care and resource utilization. Arch Intern Med 162 (2002) 682-688